Valuation : Ha Tay Pharmaceutical

Market Cap 5,063B 194M 167M 157M 143M 268M 18.38B 269M 1.86B 720M 9.41B 730M 714M 29.97B P/E 2024
109x
P/E 2025 109x
Enterprise Value 5,162B 198M 170M 160M 146M 274M 18.73B 274M 1.9B 734M 9.59B 744M 728M 30.56B EV / Sales 2024
3.89x
EV / Sales 2025 2.68x
Free-Float
25%
Yield 2024 *
-
Yield 2025 -
1 day+0.18%
1 week-1.24%
Current month-1.24%
1 month-4.12%
3 months-14.92%
6 months-19.22%
Current year-20.14%
1 week 54,800
Extreme 54800
56,700
1 month 54,400
Extreme 54400
61,000
Current year 54,400
Extreme 54400
75,800
1 year 54,400
Extreme 54400
86,800
3 years 17,090.91
Extreme 17090.90909
100,818.18
5 years 11,980.52
Extreme 11980.519478
100,818.18
10 years 4,801.26
Extreme 4801.259345
100,818.18
Manager TitleAgeSince
Chief Executive Officer 53 01/04/2016
Corporate Officer/Principal - 01/03/2016
Corporate Officer/Principal 49 04/02/2015
Director TitleAgeSince
Chairman 75 01/01/2016
Director/Board Member 53 -
Director/Board Member 62 01/06/2013
Change 5-day change 1-year change 3-year change Capi.($)
+0.18%-1.24%-29.00%+167.35% 194M
-0.88%-0.64%+58.05%+100.51% 1,024B
-1.15%+3.53%+54.25%+71.99% 663B
-1.44%+0.02%+20.65%+72.22% 453B
-0.95%+0.23%+28.96%+37.78% 349B
-3.18%+1.78%+20.66%+41.55% 295B
+0.30%+0.60%-0.40%+11.25% 253B
-1.55%+1.71%+54.15%+71.87% 236B
+0.02%+2.24%-14.59%-55.80% 206B
-0.15%+3.18%+31.24%+104.21% 187B
Average -0.88%+0.95%+22.40%+62.29% 366.75B
Weighted average by Cap. -1.06%+0.52%+37.24%+64.56%

Financials

2024 2025
Net sales 2,086B 80.06M 68.85M 64.76M 59.12M 111M 7.57B 111M 768M 297M 3.88B 301M 294M 12.35B 2,402B 92.18M 79.27M 74.56M 68.06M 127M 8.72B 128M 884M 342M 4.46B 346M 339M 14.22B
Net income 71.77B 2.75M 2.37M 2.23M 2.03M 3.8M 260M 3.82M 26.41M 10.21M 133M 10.34M 10.12M 425M 53.66B 2.06M 1.77M 1.67M 1.52M 2.84M 195M 2.85M 19.75M 7.63M 99.72M 7.73M 7.56M 318M
Net Debt 290B 11.13M 9.57M 9M 8.21M 15.36M 1.05B 15.41M 107M 41.24M 539M 41.78M 40.87M 1.72B 98.73B 3.79M 3.26M 3.06M 2.8M 5.23M 358M 5.25M 36.33M 14.04M 183M 14.23M 13.92M 584M
Logo Ha Tay Pharmaceutical
Hatay Pharmaceutical Joint Stock Company (Hataphar) is a Vietnam-based pharmaceutical company. It is engaged in the manufacturing, marketing, wholesale and retail trading, import and export of pharmaceutical products, preparations and materials, vaccines, along with medical equipment and supplies. The Company also manufactures and trades cosmetic products, supplemental food, general chemicals and specialized chemicals for laboratory tests. Other activities include supermarket operations, office and apartment leasing, real estate brokerage services, as well as the provision of vocational training services. The Company announced that it has completed the acquisition of 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company by the end of the third quarter of 2013.
Employees
586
Date Price Change Volume
07/09/26 ₫55,900.00 +0.18% 12,802
04/09/26 ₫55,800.00 +0.18% 7,707
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!